| Application no. and date | 21827282.1 (espacenet) (Federated) (European Patent Register), 20211118 | | Patent/reg. no. and date | DK/EP 4247371, 20250101 | | Publication date | 20230927 | | Priority no. and date | US 202063115165 P, 20201118 | | EP pub. no. and date |
EP 4247371 20230927 | | Effective date | | | Applicant/owner | Constellation Pharmaceuticals, Inc., 470 Atlantic Avenue, Suite 1401
Boston, MA 02210, US | | Applicant ref. no. | 1736186 | | Inventor | BRADLEY, William, D.,
Winchester, MA 01890, US,
CUI, Jike,
Belmont, MA 02478, US,
SUN, Kaiming,
Belmont, MA 02478, US,
TROJER, Patrick,
Reading, MA 01867, US,
WANG, Jing,
Lexington, MA 20420, US,
WU, Rentian,
Winchester, MA 01890, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/4166 (2006.01) , A61K 31/4433 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | EZH2-HÆMNINGSTERAPIER TIL BEHANDLING AF ANDROGENRECEPTOR-MUTEREDE PROSTATACANCERE | | Int. application no. | US2021059847 | | Int. publication no. | WO2022109106 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
